Login/Sign Up

Novo Nordisk A/S (NOVO B)

Basic

  • Market Cap

    DKK 2,847.77B

  • EV

    DKK 2,837.06B

  • Shares Out

    4,472M

  • Revenue

    DKK 201.33B

  • Employees

    59,337

Margins

  • Gross

    84.35%

  • EBITDA

    46.14%

  • Operating

    43.2%

  • Pre-Tax

    41.4%

  • Net

    33.4%

  • FCF

    35.25%

Returns (5Yr Avg)

  • ROA

    24.8%

  • ROE

    72.03%

  • ROCE

    77.29%

  • ROIC

    36.73%

Valuation (TTM)

  • P/E

    42.05

  • P/B

    31

  • EV/Sales

    14.09

  • EV/EBITDA

    30.26

  • EV/FCF

    52.97

  • EV/Gross Profit

    16.71

Valuation (NTM)

  • Price Target

    DKK 648.75

  • P/E

    34.86

  • EV/Sales

    11.84

  • EV/EBITDA

    25.05

  • EV/FCF

    37.79

Per Share

  • Rev

    DKK 44.69

  • Earnings (Dil)

    DKK 14.88

  • FCF

    DKK 15.71

  • Book Value

    DKK 20.18

Growth (CAGR)

  • Rev 3Yr

    16.73%

  • Rev 5Yr

    13.07%

  • Rev 10Yr

    9.38%

  • Dil EPS 3Yr

    19.22%

  • Dil EPS 5Yr

    13.26%

  • Dil EPS 10Yr

    12.87%

  • Rev Fwd 2Yr

    22.22%

  • EBITDA Fwd 2Yr

    23.53%

  • EPS Fwd 2Yr

    31.01%

  • EPS LT Growth Est

    20.38%

Dividends

  • Yield

    1.13%

  • Payout

    47.4%

  • DPS

    DKK 7.08

  • DPS Growth 3Yr

    18.06%

  • DPS Growth 5Yr

    12.51%

  • DPS Growth 10Yr

    14.67%

  • DPS Growth Fwd 2Yr

    24.64%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

111,831.0

122,021.0

126,946.0

140,800.0

176,954.0

201,325.0

Total Revenues % Chg.

0.1%

9.1%

4.0%

10.9%

25.7%

28.0%

Cost of Goods Sold, Total

17,617.0

20,088.0

20,932.0

23,658.0

28,448.0

31,500.0

Gross Profit

94,214.0

101,933.0

106,014.0

117,142.0

148,506.0

169,825.0

Selling General & Admin Expenses, Total

33,313.0

35,830.0

36,886.0

41,058.0

50,684.0

56,597.0

R&D Expenses

14,805.0

14,220.0

15,462.0

17,199.0

23,287.0

26,813.0

Other Operating Expenses

-1,152.0

-600.0

-460.0

-456.0

-1,085.0

-562.0

Other Operating Expenses, Total

46,966.0

49,450.0

51,888.0

57,801.0

72,886.0

82,848.0

Operating Income

47,248.0

52,483.0

54,126.0

59,341.0

75,620.0

86,977.0

Interest Expense, Total

-85.0

-220.0

-390.0

-289.0

-378.0

-378.0

Interest And Investment Income

51.0

65.0

337.0

231.0

239.0

239.0

Net Interest Expenses

-34.0

-155.0

-53.0

-58.0

-139.0

-139.0

Income (Loss) On Equity Invest.

12.0

-137.0

149.0

-24.0

-189.0

-189.0

Currency Exchange Gains (Loss)

298.0

-3,212.0

-747.0

344.0

-4,651.0

-2,523.0

Other Non Operating Income (Expenses)

-72.0

-281.0

-150.0

-122.0

-181.0

611.0

EBT, Excl. Unusual Items

47,452.0

48,698.0

53,325.0

59,481.0

70,460.0

84,737.0

Merger & Related Restructuring Charges

—

—

—

-124.0

-51.0

-51.0

Gain (Loss) On Sale Of Investments

163.0

-145.0

-195.0

296.0

-587.0

-587.0

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

Asset Writedown

—

—

—

-573.0

-760.0

-760.0

Other Unusual Items

—

—

—

—

—

—

EBT, Incl. Unusual Items

47,615.0

48,553.0

53,130.0

59,080.0

69,062.0

83,339.0

Income Tax Expense

8,987.0

9,602.0

10,992.0

11,323.0

13,537.0

16,100.0

Earnings From Continuing Operations

38,628.0

38,951.0

42,138.0

47,757.0

55,525.0

67,239.0

Net Income

38,628.0

38,951.0

42,138.0

47,757.0

55,525.0

67,239.0

Net Income to Common Incl Extra Items

38,628.0

38,951.0

42,138.0

47,757.0

55,525.0

67,239.0

Net Income to Common Excl. Extra Items

38,628.0

38,951.0

42,138.0

47,757.0

55,525.0

67,239.0

Total Shares Outstanding

4,788.0

4,704.0

4,625.0

4,557.8

4,500.7

4,482.2

Weighted Avg. Shares Outstanding

4,839.2

4,748.6

4,667.8

4,593.2

4,530.6

4,505.0

Weighted Avg. Shares Outstanding Dil

4,848.8

4,757.4

4,680.0

4,606.2

4,544.6

4,518.8

EPS

8.0

8.2

9.0

10.4

12.3

14.9

EPS Diluted

8.0

8.2

9.0

10.4

12.2

14.9

EBITDA

51,173.0

56,310.0

58,565.0

63,553.0

80,926.0

92,893.0